Episodes

  • Edition 25: Breaking the Stigma Around Cannabis

    Edition 25: Breaking the Stigma Around Cannabis
    Mar 27 2024

    In this 25th Edition of the Panama Interview Series we are honored to have as our guest Benjamin Larson, CEO at Vertosa.Vertosa creates industry-leading active ingredients for infused product makers. Vertosa’s patent pending nano- and micro-emulsions are carefully designed for the specific needs of each of our customers. Vertosa’s pre-suspended aqueous solutions empower manufacturers and brand owners to create incredibly homogenous and stable products while maximizing bioavailability, clarity, and taste. Vertosa works closely with its clients and its lab partners throughout the manufacturing process to achieve target potency and accelerate the go-to-market process.We will discuss Vertosa’s mission to break the stigma around cannabis, unlock impactful truths by making cannabis accessible to all, and develop the best cannabinoid delivery mechanisms and create unique experiences.

    We invite you to view this event that streamed on LinkedIn Thursday November 16 at 11 AM EST.

    Watch.

    Learn.

    Boost Profit Through Expansion in Latin America and the Caribbean!
    Show more Show less
    54 mins
  • Edition 24: Recent Developments in the Regulation of Cannabis-Derived Products in the Americas

    Edition 24: Recent Developments in the Regulation of Cannabis-Derived Products in the Americas
    Oct 16 2023
    In this 24th Edition of the Panama Interview Series we are honored to have as our guest Dr. Sandra Carrillo, Professor Faculty of Medicine Panama University, Medical Director & Co-Founder of Medicann IPS Medical Cannabis Clinics, and President Colombian Medical Cannabis Association. MEDICANN IPS, is a Health Provider Institution, formed by a group of medical experts in the formulation of preparations from medical cannabis that leads in Colombia the attention to patients interested in complementing their treatments with this type of products, offering a specialized advisory service to formulate cannabis derivatives that have shown evidence in the treatment of chronic diseases, privileging security in its administration and taking care not to harm its users. The Colombian Medical Cannabis Association promotes and supports education based on scientific evidence and cannabis research medicinal to promote responsible use in Colombia. We will discuss Recent Developments in the Regulation of Cannabis-Derived Products in the Americas. We invite you to listen this event that streamed live on LinkedIn Thursday September 7 at 11 AM EST. Watch. Learn. Boost Profit Through Expansion in Latin America and the Caribbean!
    Show more Show less
    44 mins
  • Edition 23: Developments in the Regulation of Cannabis Derived Products in the Americas

    Edition 23: Developments in the Regulation of Cannabis Derived Products in the Americas
    Aug 7 2023
    In this 23rd Edition of the Panama Interview Series we are honored to have as our guest Sheri L. Orlowitz, Founder, Chair of the Board of the Council for Federal Cannabis Regulation (CFCR). The Council for Federal Cannabis Regulation (CFCR) is a 501(c)(3) non-profit based in Washington, DC. The mission of CFCR is to legitimize cannabis by assisting the federal government, its regulatory agencies, and industry to rethink, develop, and implement evidence-based cannabis regulations. CFCR brings together the stakeholders of the cannabis industry and the federal government to create a safe and sensible marketplace. We will discuss Recent Developments in the Regulation of Cannabis-Derived Products in the Americas. We invite you to attend this event that will live stream on LinkedIn Friday July 14, 11 AM EST. Watch. Learn. Boost Profit Through Expansion in Latin America and the Caribbean!
    Show more Show less
    44 mins
  • Industrial Scale Microbiome Mining - Implications for LATAM

    Industrial Scale Microbiome Mining - Implications for LATAM
    Jun 27 2023
    On June 15, 2023, at 2pm EST, BICO Legal and Compliance Consulting, LLC hosted a LinkedIn Live Event with Ross Youngs, CEO & Founder Biosortia, Inc. – Microbiomics.- Biosortia is building the world’s largest library of microbiome-derived compounds for therapeutic and other applications, by leveraging the company’s microbial harvesting platform to sample and mine aquatic microbiomes at unprecedented scales with sustainable and environmentally friendly approaches.- Biosortia’s breakthrough technology now effectively opens the door to all microbes, making thousands of novel chemical entities available for therapeutic and other applications.- Ross and Biosortia are seeking partners interested in accessing compounds and chemistries to develop biologically relevant small molecule leads.We learned a great deal from Ross’s insights regarding the promise of at scale mining of nature’s metabolite bounty and the opportunity to discuss its applications in Latin America and the Caribbean.We invite you to listen. Watch. Learn. Boost Profit Through Expansion in Latin America and the Caribbean!#latinamerica #probiotics #microbiome #digestivehealth #postcovidrecovery #research #pharma #startups #ceo #guthealth #microbiology #drugdiscovery
    Show more Show less
    1 hr
  • Edition 21: Real Life Applications of Microbiome Research Implications for LATAM

    Edition 21: Real Life Applications of Microbiome Research Implications for LATAM
    May 23 2023
    Welcome to the 21st edition of the Panama Interview Series where we discuss topics regarding foreign direct investment in Latin America and the Caribbean. In this edition we discuss the future of probiotics in Latin America with a focus on Real-Life Applications of Microbiome Research and their implications for Latin America and the Caribbean. We are honored to have as our guest Dr. Aamine Zorgani, microbiome expert and author of the recently published audio book "Microbiome Mavericks". We look forward to his insights regarding the lessons learned from the current approaches in the probiotics field, and the challenges and future steps required for the development of postbiotics, with an emphasis on applications in Latin America.
    Show more Show less
    1 hr
  • Edition 20: Future of Probiotics in Latin America and the Caribbean - Focus Postbiotics

    Edition 20: Future of Probiotics in Latin America and the Caribbean - Focus Postbiotics
    Apr 21 2023

    Welcome to the 20th edition of the Panama Interview Series where we discuss topics regarding foreign direct investment in Latin America and the Caribbean. In this edition we discuss the future of probiotics in Latin America with a focus on Postbiotics.

    In this the 20th Edition of the Panama Interview Series, we are honored to have as our guest Michael Hsiao, Sales Manager, International Business Department, Glac Biotech Co., Ltd.

    We look forward to his insights regarding the lessons learned from the current approaches in the probiotics field, and the challenges and future steps required for the development of postbiotics, with an emphasis on applications in Latin America.

    ***

    - The growth of the digestive health category has been a nutrition industry success story.- Ingredients with digestive health benefits now command very high levels of consumer awareness, and this is particularly true of probiotics.

    - The global probiotics market is projected to grow to $69 billion at a CAGR of 7.0% through 2023.- Functional foods and beverages are by far the biggest segment for probiotics, currently standing at $40 billion and representing more than 82% of the total market.

    - The LATAM region offers the most significant potential for growth of the functional foods industry over the coming years. The market for probiotics and digestive health products in Venezuela experienced significant growth pre-COVID19 and has great promise for continued growth post-COVID.
    Show more Show less
    49 mins
  • Edition 18: Future of Probiotics in Latin America and the Caribbean - Focus Precision Probiotics

    Edition 18: Future of Probiotics in Latin America and the Caribbean - Focus Precision Probiotics
    Feb 22 2023

    Welcome to the 18th edition of the Panama Interview Series where we discuss topics regarding foreign direct investment in Latin America and the Caribbean.

    Today we focus on the emerging development modality of Precision Probiotics which promises to significantly improve the efficacy of probiotics and enable manufacturers and brand owners of probiotic supplements to identify the best probiotic strains for the specific health targets of individual consumers. The promise of Precision Probiotics is the application of probiotics to “personalized” nutrition and preventive medicine. Exciting stuff!

    To that end, we are honored to have as our guests Jordi Riera, Chief Business Development Manager, Kaneka Probiotics.

    Kaneka Probiotics is a division of Kaneka Americas Holding, Inc., and is a leader in the development of scientifically based ingredients for the global nutrition industry. Kaneka Probiotics is committed to promoting business development to provide solutions that support healthy and energetic lives.

    As Chief Business Development Manager at Kaneka Probiotics, Jordi Riera is responsible for strategic account management, innovation and product development, and the technical support of sales, marketing, and educational initiatives. Jordi has been responsible for the launch of over 250 probiotic products in more than 90 markets worldwide.
    Show more Show less
    1 hr and 3 mins